Literature DB >> 25787729

Multifunctional nanoparticles for use in theranostic applications.

James T Cole1, Nolan B Holland.   

Abstract

Theranostics is a promising field that combines therapeutics and diagnostics into single multifunctional formulations. This field is driven by advancements in nanoparticle systems capable of providing the necessary functionalities. By utilizing these powerful nanomedicines, the concept of personalized medicine can be realized by tailoring treatment strategies to the individual. This review gives a brief overview of the components of a theranostic system and the challenges that designing truly multifunctional nanoparticles present. Considerations when choosing a class of nanoparticle include the size, shape, charge, and surface chemistry, while classes of nanoparticles discussed are polymers, liposomes, dendrimers, and polymeric micelles. Targeting to disease states can be achieved either through passive or active targeting which uses specific ligands to target receptors that are overexpressed in tumors and common targeting elements are presented. To image the interactions with disease states, contrast agents are included in the nanoparticle formulation. Imaging options include optical imaging techniques, computed tomography, nuclear based, and magnetic resonance imaging. The interplay between all of these components needs to be carefully considered when designing a theranostic system.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25787729     DOI: 10.1007/s13346-015-0218-2

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  12 in total

Review 1.  Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway.

Authors:  Zhong Ming Qian; Hongyan Li; Hongzhe Sun; Kwokping Ho
Journal:  Pharmacol Rev       Date:  2002-12       Impact factor: 25.468

Review 2.  RGD modified polymers: biomaterials for stimulated cell adhesion and beyond.

Authors:  Ulrich Hersel; Claudia Dahmen; Horst Kessler
Journal:  Biomaterials       Date:  2003-11       Impact factor: 12.479

3.  Drug delivery systems: entering the mainstream.

Authors:  Theresa M Allen; Pieter R Cullis
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

4.  Cancer statistics, 2014.

Authors:  Rebecca Siegel; Jiemin Ma; Zhaohui Zou; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-07       Impact factor: 508.702

Review 5.  Targeted drug delivery via the folate receptor.

Authors:  J Sudimack; R J Lee
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

7.  Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer.

Authors:  Kimberley M Laginha; Elaine H Moase; Ning Yu; Anthony Huang; T M Allen
Journal:  J Drug Target       Date:  2008-08       Impact factor: 5.121

8.  Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy.

Authors:  K Kitamura; T Takahashi; T Yamaguchi; A Noguchi; A Noguchi; K Takashina; H Tsurumi; M Inagake; T Toyokuni; S Hakomori
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

Review 9.  Therapeutic nanoparticles for drug delivery in cancer.

Authors:  Kwangjae Cho; Xu Wang; Shuming Nie; Zhuo Georgia Chen; Dong M Shin
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

10.  Development of NGR peptide-based agents for tumor imaging.

Authors:  Rongsheng E Wang; Youhong Niu; Haifan Wu; Mohamad Nassir Amin; Jianfeng Cai
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-07-03
View more
  14 in total

1.  Radio-nanomaterials for biomedical applications: state of the art.

Authors:  Weifei Lu; Hao Hong; Weibo Cai
Journal:  Eur J Nanomed       Date:  2016-02-06

2.  Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.

Authors:  Andrzej S Pitek; Slater A Jameson; Frank A Veliz; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomaterials       Date:  2016-02-23       Impact factor: 12.479

3.  Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy.

Authors:  M Luísa Corvo; Ana Soraia Mendo; Sara Figueiredo; Rogério Gaspar; Miguel Larguinho; M Fátima C Guedes da Silva; Pedro Viana Baptista; Alexandra R Fernandes
Journal:  Pharm Res       Date:  2016-03-31       Impact factor: 4.200

Review 4.  Nanomedicine, a valuable tool for skeletal muscle disorders: Challenges, promises, and limitations.

Authors:  Valentina Colapicchioni; Francesco Millozzi; Ornella Parolini; Daniela Palacios
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-29

Review 5.  Targeted Radionuclide Therapy of Human Tumors.

Authors:  Sergey V Gudkov; Natalya Yu Shilyagina; Vladimir A Vodeneev; Andrei V Zvyagin
Journal:  Int J Mol Sci       Date:  2015-12-28       Impact factor: 5.923

Review 6.  Photoacoustic-Based Multimodal Nanoprobes: from Constructing to Biological Applications.

Authors:  Duyang Gao; Zhen Yuan
Journal:  Int J Biol Sci       Date:  2017-02-25       Impact factor: 6.580

Review 7.  Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?

Authors:  Pedro Pedrosa; Raquel Vinhas; Alexandra Fernandes; Pedro V Baptista
Journal:  Nanomaterials (Basel)       Date:  2015-11-03       Impact factor: 5.076

Review 8.  Advances and Challenges of Liposome Assisted Drug Delivery.

Authors:  Lisa Sercombe; Tejaswi Veerati; Fatemeh Moheimani; Sherry Y Wu; Anil K Sood; Susan Hua
Journal:  Front Pharmacol       Date:  2015-12-01       Impact factor: 5.810

9.  Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application.

Authors:  Yongwei Hao; Lei Wang; Bingxiang Zhang; Dong Li; Dehui Meng; Jinjin Shi; Hongling Zhang; Zhenzhong Zhang; Yun Zhang
Journal:  Int J Nanomedicine       Date:  2016-04-29

10.  Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.

Authors:  Jun Li; Jing Liu; Shengnan Li; Yanli Hao; Lei Chen; Xiaoning Zhang
Journal:  Oncotarget       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.